Clinical Information > Pharmacy Providers

HOW SUPPLIED:
ANADROL®-50 (oxymetholone) Tablets is supplied in bottles of
100 (NDC 0051-8633-33) white scored tablets. Keep out of
reach of children. Dispense in a tight, light resistant container.

STORAGE:
Store at controlled room temperature 20° to 25°C (68° to 77°F);
excursions permitted to 15° to 30°C (59° to 86°F) [See USP].

Click here to download a Pharmacy Fact Sheet.

Rx Only
Manufactured for:
ALAVEN Pharmaceutical
Marietta, GA 30067
Anadrol-50 is a registered trademark of Alaven™ Pharmaceutical

0055 Rev Jun 2006 © 2006 ALAVEN Pharmaceutical
ANADROL-50
(oxymetholone)
50 mg Tablets

MANAGED CARE/ MEDICARE/MEDICAID:

Anadrol-50 is covered under most all Insurance Plans through a Prior Authorization

BILLING CODES:

ICD-9
285.9Anemia; 285.0 - Erythropoiesis, idiopathic, ineffective; 284.9 - Hypoplasia, bone marrow; 289.8 - Myelofibrosis (osteosclerosis); 799.4 - Cachexia

HCPCS Code for Anadrol-50
J3490            Unclassified Drug

DRUG INTERACTIONS:

Warfarin: Clinically significant pharmacokinetic and pharmacodynamic interactions between anabolic steroids and warfarin have been reported in healthy volunteers. When anabolic steroid therapy is initiated in a patient already receiving treatment with warfarin, the INR (international normalized ratio) or prothrombin time (PT) should be monitored closely and the dose of warfarin adjusted as necessary until a stable target INR or PT has been achieved. Furthermore, in patients receiving both ANADROL-50 Tablets and warfarin, careful monitoring of the INR or PT and adjustment of the warfarin dosage, if indicated, are recommended when the ANADROL-50
dose is changed or discontinued. Patients should be closely monitored for signs and symptoms of occult bleeding.

Anticoagulants: Anabolic steroids may increase sensitivity to oral anticoagulants. Dosage of the anticoagulant may have to be decreased in order to maintain the desired prothrombin time. Patients receiving oral anticoagulant therapy require close monitoring, especially when anabolic steroids are started or stopped.

SEE FULL BOXED WARNING FOR MORE INFORMATION ON THESE CONDITIONS IN THE FULL PRESCRIBING INFORMATION.

Home | Clinical Information | Patient Information | News | Links | Contact Us